Dipen Patel | Internal Medicine | Best Researcher Award

Published on by Academic Awards

Dr. Dipen Patel | Internal Medicine | Best Researcher Award

The Ohio State University Comprehensive Cancer Center | United States

Dr. Dipen Patel, Assistant Professor in the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center, is an accomplished clinician-researcher specializing in neuroendocrine and thyroid malignancies. His research emphasizes innovative diagnostic and therapeutic strategies, including targeting anti-apoptotic pathways, immunotherapy for anaplastic thyroid cancer, and multidisciplinary management of advanced thyroid and neuroendocrine tumors. Dr. Patel has an extensive publication record with impactful articles in Endocrine Practice, Annals of Surgical Oncology, Thyroid, and Endocrine-Related Cancer, alongside numerous abstracts and presentations at ASCO, NANETS, ENETS, and ACG, highlighting translational relevance that bridges clinical care and research. With a documented h-index of 1, three scholarly documents, and one citation, his work demonstrates growing influence in the field, establishing him as a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

Patel, D., Sukrithan, V., Ahmed, U., Krause, H., Gandhi, N., Elliott, A., Hinton, A., Walker, P., Vanderwalde, A., Zhou, Y., Lou, E., Soares, H. P., Rogers, K. A., & Konda, B. (2025). Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms. Endocrine-Related Cancer, 32(7), e240341.

Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Prof. Liancheng Zhu | Medicine and Dentistry | Best Researcher Award

Prof. Liancheng Zhu , Medicine and Dentistry , China Medical University, China

Dr. Zhu Liancheng is a highly respected professor of Obstetrics and Gynecology at Shengjing Hospital of China Medical University in Shenyang, Liaoning Province, China. He earned his doctor’s degree in Obstetrics and Gynecology from China Medical University.Dr. Zhu has a deep commitment to advancing women’s health through his expertise in gynecologic oncology, particularly in ovarian and endometrial cancers. With a distinguished career in clinical practice and research, he has contributed significantly to the study of molecular markers, gene expression profiles, and cancer treatment strategies in gynecological malignancies. His work has been published in leading international medical journals, and his research has garnered attention for its impact on cancer prognostication and therapeutic approaches. Dr. Zhu’s ongoing research continues to influence gynecologic oncology, focusing on improving cancer detection, prognosis, and treatment in women worldwide.

Publication Profile

Scopus 

Academic Background🎓

Dr. Zhu Liancheng completed his medical education at China Medical University, Liaoning Province, China, where he earned his Doctor’s degree in Obstetrics and Gynecology in 2015. His academic foundation in gynecology was followed by extensive training and research in the field of women’s reproductive health, particularly focusing on gynecologic oncology. Dr. Zhu’s education has provided him with the expertise to explore the molecular and clinical aspects of gynecologic cancers, such as ovarian and endometrial cancers. He has undertaken advanced studies in cancer genomics, tumor markers, and the molecular mechanisms behind chemoresistance, with particular emphasis on gene expression analysis. This rigorous academic background has enabled him to make meaningful contributions to both clinical practice and the advancement of medical knowledge in the field of obstetrics and gynecology. His work has led to multiple publications and a broad recognition in the field of gynecologic cancer research.

Professional Background🏅

Dr. Zhu Liancheng is a professor in Obstetrics and Gynecology at Shengjing Hospital of China Medical University, where he has gained significant experience in both clinical practice and research. His clinical expertise includes diagnosing and treating complex gynecological conditions, particularly cancers such as ovarian, endometrial, and cervical cancers. He has contributed to the development of treatment protocols and strategies aimed at improving patient outcomes in gynecologic oncology. Dr. Zhu has also been deeply involved in translational research, studying molecular biomarkers and gene expression profiles that influence cancer progression and chemoresistance. His research has provided insights into the genetic mechanisms behind cancer prognosis and the development of targeted therapies. His role as a mentor for medical students, residents, and researchers further underscores his leadership in advancing gynecologic oncology. With a strong clinical and academic foundation, Dr. Zhu continues to make a significant impact on both patient care and scientific advancements.

Awards and Honors🏆

Dr. Zhu Liancheng’s outstanding contributions to the field of Obstetrics and Gynecology, particularly in gynecologic oncology, have earned him recognition from both national and international medical communities. Although specific awards are not listed, his extensive publication record, including numerous influential articles in leading medical journals, underscores his recognition as an expert in the field. His research on ovarian and endometrial cancers, gene expression profiles, and treatment resistance has been widely cited, demonstrating the impact of his work. Dr. Zhu has been invited to present at various national and international conferences, further solidifying his status as a thought leader in gynecologic oncology. Additionally, his role in advancing clinical practices and contributing to the development of prognostic tools for cancer patients reflects the high regard in which he is held by his peers. Dr. Zhu’s work continues to influence the future of gynecologic cancer research and treatment.

Research Focus🔬

Dr. Zhu Liancheng’s research primarily focuses on the molecular mechanisms behind gynecological cancers, with particular emphasis on ovarian and endometrial cancers. His work aims to identify novel biomarkers and genetic profiles that can predict cancer prognosis, progression, and response to therapy. Through gene expression analysis and the study of various molecular markers, Dr. Zhu seeks to enhance the understanding of how these cancers develop and metastasize, particularly focusing on chemoresistance and the role of tumor-associated genes. His research has contributed to identifying potential therapeutic targets, such as human epididymis protein 4 (HE4) and α1,2-fucosyltransferase (FUT1), which may offer new approaches to cancer treatment. Dr. Zhu’s work in gynecologic oncology is essential for improving the survival rates and quality of life for women with ovarian and endometrial cancers. His research also bridges the gap between laboratory findings and clinical applications, offering new hope for more effective treatment strategies in gynecological oncology.

Publication Top Notes

Integration of scRNA-seq and bulk RNA-seq to reveal the association and potential molecular mechanisms of metabolic reprogramming regulated by lactylation and chemotherapy resistance in ovarian cancer

Erratum: Retraction notice to “Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer”

Corrigendum: SERPIND1 affects the malignant biological behavior of epithelial ovarian cancer via the PI3K/AKT pathway: a mechanistic study

Ferroptosis: mechanism, immunotherapy and role in ovarian cancer

Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options

Citations: 2

Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer

Citations: 5

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature

Citations: 2

Conclusion

Dr. Zhu Liancheng is highly deserving of the “Best Researcher Award” due to his outstanding and impactful research in the field of gynecologic oncology. His contributions to understanding the molecular underpinnings of ovarian and endometrial cancers, particularly his work on gene expression profiles and chemotherapy resistance, have had a profound impact on the field. His research not only furthers the understanding of cancer biology but also provides insights that could lead to better treatments and improved survival rates for women with these cancers. Dr. Zhu’s combination of clinical expertise, innovative research, and dedication to advancing women’s health positions him as a leader in his field. The breadth and depth of his work, coupled with his extensive publication record, make him a deserving candidate for this prestigious recognition. His influence on the future of gynecologic oncology is immense, and he continues to inspire and lead groundbreaking research efforts in the medical community.

 

 

Álvaro Castellanos | Medicine | Innovation in Education Excellence Award

Published on by Academic Awards

Assoc. Prof. Dr. Álvaro Castellanos | Medicine | Innovation in Education Excellence Award

Assoc. Prof. Dr. Álvaro Castellanos, HOSPITAL UNIVERSITARIO Y POLITÉCNICO LA FE DE VALENCIA, Spain

Dr. Álvaro Castellanos Ortega is a highly esteemed Associate Professor of Medicine and the Head of the Intensive Care Department at Hospital Universitario y Politécnico La Fe in Valencia. He earned his Medical degree from the University of Valladolid and completed his PhD at the University of Cantabria. With extensive expertise in intensive care and medical education, Dr. Castellanos has contributed significantly to research in infection, sepsis, and training. He has authored 63 indexed publications, and his work on competence-based medical education has earned multiple prestigious awards, including the ESICM Trials Group Award. He is also actively involved in European medical education initiatives.

Publication Profile

Orcid

Professional Qualifications 🏥

Assoc. Prof. Dr. Álvaro Castellanos is a distinguished medical professional with a strong academic and clinical background. He graduated in Medicine and Surgery from the University of Valladolid (1979) and earned his PhD with honors from the University of Cantabria (1998), focusing on a prognostic scoring system for meningococcal septic shock in children. He specialized in Intensive Care Medicine, completing his training at Hospital Universitario Marqués de Valdecilla. Dr. Castellanos serves as Head of the Intensive Care Medicine Department at Hospital Universitario y Politécnico La Fe de Valencia. He is also an Associate Professor at the University of Valencia and an EDIC examiner. Additionally, he holds a Master’s in Healthcare Administration from the University of Cantabria. 🌟

 

 

Awards and Recognitions

Assoc. Prof. Dr. Álvaro Castellanos has earned numerous prestigious awards throughout his career. He won the First Prize for Quality Improvement of Care from the Regional Healthcare Service of Cantabria in 2008. His initiative on implementing the Surviving Sepsis Campaign during residency also received recognition. In 2017, he earned the First Prize for Best Patient Safety Initiatives for his rapid response system project. Dr. Castellanos was awarded the Best Project in Postgraduate Teaching by the Lilly Foundation for his electronic portfolio for specialists. Additionally, he received the ESICM Trials Group Award for his research on medical education in intensive care. 🌟

 

 

Research Focus

Dr. Álvaro Castellanos-Ortega is an Associate Professor with significant contributions in intensive care medicine, particularly related to medical education and patient safety in critically ill patients. He has been involved in multiple research projects focusing on pharmacokinetics in critically ill patients, including studies on Cefiderocol, Isavuconazole, and other medications. Dr. Castellanos-Ortega has authored and co-authored numerous articles on intensive care topics such as COVID-19 management, heart transplantation, and training programs for intensive care medicine. His work is widely published in journals like Medicina Intensiva and Critical Care, contributing significantly to the improvement of clinical practices in intensive care units.

 

 

Publication Top Notes

  • Effect of a Competence-Based Medical Education Program on Training Quality in Intensive Care Medicine. COBALIDATION TRIAL.
    Medicina Intensiva (2025-01-03)
    DOI: 10.1016/j.medine.2024.502126
    PMID: 39755447
    Contributors: Castellanos-Ortega Á, Broch Porcar MJ, Palacios-Castañeda D, et al.
  • Cefiderocol Pharmacokinetics in Critically Ill Patients Undergoing ECMO Support.
    Critical Care (2024-10-18)
    DOI: 10.1186/s13054-024-05126-4
    PMID: 39425201
    PMC: PMC11488226
    Contributors: Marín-Cerezuela M, Martín-Latorre R, Frasquet J, et al.
  • Reply to “Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?”
    Medicina Intensiva (2024-10-05)
    DOI: 10.1016/j.medine.2024.07.013
    PMID: 39368886
    Contributors: Broch Porcar MJ, Castellanos-Ortega Á
  • Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends Over Time.
    Biomedicines (2024-09-16)
    DOI: 10.3390/biomedicines12092109
    PMID: 39335622
    PMC: PMC11428817
    Contributors: López Vilella R, Pérez Guillén M, Borja Guerrero Cervera, et al.
  • Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
    Antibiotics (2024-07-29)
    DOI: 10.3390/antibiotics13080706
    PMID: 39200006
    PMC: PMC11350865
    Contributors: Martín Cerezuela M, Gallegos C, Marqués-Miñana MR, et al.
  • Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?
    Medicina Intensiva (2024-05-25)
    DOI: 10.1016/j.medine.2024.04.012
    PMID: 38797620
    Contributors: Broch Porcar MJ, Castellanos-Ortega Á
  • “INTUPROS”: An Opportunity to Reflect Upon and Improve.
    Medicina Intensiva (2024-05-06)
    DOI: 10.1016/j.medine.2024.04.014
    PMID: 38714391
    Contributors: Viviani A, Vicent C, Castellanos-Ortega Á
  • Mentoring Programme: Guiding Your First Steps Towards Scientific Excellence.
    Medicina Intensiva (2023-03-21)
    DOI: 10.1016/j.medine.2023.03.006
    PMID: 36948924
    Contributors: Lobo-Valbuena B, Galarza Barrachina L, Albillos Almaraz R, et al.
  • Effects of Intubation Timing in Patients with COVID-19 Throughout the Four Waves of the Pandemic: A Matched Analysis.
    The European Respiratory Journal (2023-03-02)
    DOI: 10.1183/13993003.01426-2022
    PMID: 36396142
    PMC: PMC9686319
    Contributors: Riera del Brio J, Barbeta E, Tormos A, et al.
  • Driving Pressure and Adjunctive Therapies in Pulmonary Sequelae of COVID-19 Patients Under Invasive Ventilation.
    Intensive Care Medicine (2023-01-25)
    DOI: 10.1007/s00134-022-06951-3
    PMID: 36695836
    PMC: PMC9875751
    Contributors: González J, Iván David Benítez, Ana Motos, et al.

 

Tiantian Zhang | Health Professions | Best Researcher Award

Published on by Academic Awards

Dr. Tiantian Zhang | Health Professions | Best Researcher Award

Dr. Tiantian Zhang, Fudan University, China

Dr. Tiantian Zhang is a dedicated researcher in the field of public health, specializing in the construction of public health systems and proactive health technologies within the context of medical health big data. Currently serving as a Youth Researcher at the School of Public Health at Fudan University since October 2023, she brings an academic background with a Master’s and Doctorate in Management, focusing on social medicine and health management from Fudan University. She has contributed significantly to over 38 publications, with many in high-impact journals, particularly in health policy, public health emergency responses, and chronic disease prevention. Her research also covers the intersection of technology, public health, and healthcare systems. She has been involved in various research projects and has received substantial funding for her work. Dr. Zhang’s academic journey includes postdoctoral research and entrepreneurial experience in management science and data science. Additionally, she is a key member of national projects on public health and disease prevention.

 

Publication Profile

Scopus

Academic Background 🎓📚

Dr. Tiantian Zhang pursued her graduate studies at Fudan University, where she earned a Master’s degree in Management with a focus on Social Medicine and Health Administration from September 2016 to June 2018. 🏫🎓 She continued her academic journey at Fudan, completing a PhD in Management in the same field from June 2018 to June 2021. 🔬 Her doctoral research contributed to advancing public health management and policy, further establishing her expertise in healthcare systems and social medicine. Dr. Zhang’s academic foundation laid the groundwork for her current work in public health and health data research. 🌟📊

 

Professional and Visiting Scholar Experience 💼🌍

Dr. Tiantian Zhang has held various esteemed positions in her career. Since October 2023, she has been serving as a Youth Researcher at Fudan University, focusing on Health Management. 🏫🧑‍🔬 From June 2021 to September 2023, she worked as a Postdoctoral Researcher at Fudan University, specializing in Public Policy. 📜🔍 Additionally, since September 2017, Dr. Zhang has been the founder and legal representative of Shanghai Haiyu Information Technology Co., Ltd., where she applies her expertise in Management Science and Data Science. 💻📊 Her diverse roles reflect her commitment to advancing healthcare and policy through innovation. 🌟

 

Research Achievements and Contributions 📚🏆

Dr. Tiantian Zhang, a Youth Researcher at Fudan University’s School of Public Health, has made significant contributions to healthcare management research. She has co-authored 9 policy briefs, receiving positive feedback from top political leaders, including members of the Central Political Bureau. 👩‍🔬✨ She has led a National Natural Science Foundation Youth Project and 7 provincial projects, while also contributing to major national R&D initiatives. Her research includes 37 published papers, 8 of which are in high-impact journals (SCI/SSCI, JCR-Q1), with a total impact factor of 68.5. 📝📊 Dr. Zhang has received multiple prestigious awards, including the Shanghai Decision-Making Advisory Research Awards and the Shanghai Youth Medal. 🏅

 

Academic Positions and Editorial Roles 📚🌟

Dr. Tiantian Zhang holds several prestigious academic roles. She is a Youth Elite Talent for the Shanghai Municipal Government Decision-Making Consulting Research Base (2024–2026) and an expert in Shanghai’s healthcare reform (2022–2025). 🏅 She serves on the Youth Committee of the Shanghai Medical Association’s Health Management Branch and is a director of the Chinese Medicine Informatics Society. 🩺 Additionally, she contributes to several academic journals, including Chinese Hospital Management and Chinese Public Health Management, where she holds youth editorial board positions. ✍️ She is also involved in writing and editing key publications, including the fifth edition of Health Management and the Blue Book on Proactive Health and Healthy Aging. 📖

 

Research Focus

Dr. Tiantian Zhang’s research focuses on public health management, health policy, and health data science. She is particularly interested in the intersection of healthcare system development and technology for proactive health and aging. 🏥 Her work includes studies on health equity, air pollution, dyslipidemia, and disease prevention, and she frequently contributes to research on health disparities and socioeconomic factors affecting public health. 🌍 Additionally, she explores health management practices and decision-making frameworks for improving healthcare services, with a strong emphasis on government regulation and community-based health interventions. 📊

 

Publication Top Notes  

  • Association of circadian syndrome with risk of hyperuricemia among middle-aged and older adults in China – 2025 🕰️,
  • Research on government regulation methods for the spatial layout of retail pharmacies – 2024 🏪
  • Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai – 2024 ⚖️,
  • Global Justice Index Report 2023 – 2024 🌍, Cited by: 2 📑.
  • Association of long-term exposure to air pollutants with sensory impairment in middle-aged and elderly adults – 2024 🌫️
  • Equity analysis of older adult resource allocation in China – 2024 💼
  • Development of an assessment tool for designated medical institutions in China – 2024 💻
  • Association of indoor solid fuel use and long-term exposure to ambient PM2.5 with sarcopenia in China – 2023 🌫️, Cited by: 10 📑.
  • Global Justice Index Report 2022 – 2023 🌍, Cited by: 7 📑.

 

Chun-Feng Huang | Health Professions | Best Researcher Award

Published on by Academic Awards

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Zhushanying Zhang | Health Professions | Best Researcher Award

Published on by Academic Awards

Assist. Prof. Dr. Zhushanying Zhang | Health Professions | Best Researcher Award

Assist. Prof. Dr. Zhushanying Zhang, South-Central Minzu University, China

Dr. Zhushanying Zhang holds a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering, Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led multiple National Natural Science Foundation of China-funded projects and received special funding for basic scientific research. He has published over ten academic papers and holds three invention patents. His work includes advancing Fourier infrared spectroscopy for noninvasive diabetes diagnosis through blood, urine, and saliva samples. 🔬📑💡

 

Publication Profile

Scopus

Academic and Professional Background

Assist. Prof. Dr. Zhushanying Zhang graduated with a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering at Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led and participated in several research projects funded by the National Natural Science Foundation of China, alongside special funding for basic scientific research from central universities. He has published over ten high-quality academic papers as the first or corresponding author and holds three invention patents. 📚💡📑

 

Research and Innovations

Assist. Prof. Dr. Zhushanying Zhang has led multiple innovative research projects focused on non-invasive detection technologies. His completed projects include the “Highly Accurate Glucose Detection Using Mid-Infrared Absorption Spectroscopy” (2022-2023, 50,000 Yuan) and “Non-invasive Uric Acid Detection by Near-Infrared Spectroscopy” (2018-2020, 40,000 Yuan), both funded by the Fundamental Research Funds for Central Universities. He also presided over the “Non-invasive Detector for Human Weak Components” (2021-2023, 100,000 Yuan) and “Human Saliva Infrared Spectroscopy Detection” (2022-2023, 500,000 Yuan). His work in Fourier infrared spectroscopy offers promising advancements for diabetes diagnosis using blood, urine, and saliva samples. 🧬📊

 

Research Areas

Assist. Prof. Dr. Zhushanying Zhang’s research spans across multiple cutting-edge fields. His expertise in infrared spectroscopy and fiber optic sensing focuses on non-invasive medical diagnostics, particularly for glucose and uric acid detection. Utilizing machine learning techniques, he enhances the accuracy and efficiency of sensor data analysis. His work in medical sensing aims to revolutionize healthcare by developing innovative detection technologies. Additionally, Dr. Zhang applies chemometrics to optimize data interpretation, advancing the potential of these technologies for real-world applications, especially in diagnostics and healthcare monitoring. 🔍💡📈

 

Publication Top Notes  

  1. “Advances in Fourier infrared spectroscopy for noninvasive diagnosis of diabetes mellitus: Analysis and prospects for application based on blood, urine, and saliva samples” (2024) 📄
  2. “Precise measurement of human heart rate based on multi-channel radar data fusion” (2024) 📄
  3. “A comprehensively improved local binary pattern framework for texture classification” (2024) 📄
  4. “Identifying the Role of Disulfidptosis in Endometrial Cancer via Machine Learning Methods” (2023) 📄 | Cited by 1
  5. “Quantitative Analysis of Hemoglobin Based on SiPLS-BP Model” (2023) 📄 | Cited by 2
  6. “Texture classification combining improved local binary pattern and threshold segmentation” (2023) 📄 | Cited by 12
  7. “Mid-infrared spectroscopy with an effective variable selection method based on MPA for glucose detection” (2023) 📄 | Cited by 5
  8. “Influencing Factors of Mid-Infrared Spectrum Blood Glucose Detection” (2023) 📄 | Cited by 2
  9. “Quantitative Analysis of Hemoglobin Based on SiPLS-SPA Wavelength Optimization” (2023) 📄 | Cited by 3
  10. “Thermal performance of LED filament in flip-chip packaging manufactured for different correlated color temperature” (2021) 📄 | Cited by 1

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes  

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

 

 

 

Fei Yu | Medicine and Dentistry | Best Researcher Award

Published on by Academic Awards

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Published on by Academic Awards

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

 

 

khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Published on by Academic Awards

Dr. khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Dr. khadijeh kalanfarmanfarma, Kashan University of Medical Sciences, Kashan, Iran

Dr. Khadijeh Kalan Farmanfarma (born April 24, 1978) holds a PhD in Epidemiology and an M.Sc. in Health Education and Promotion. She has been recognized as a top researcher at both the national and university levels, notably at Zahedan University of Medical Sciences. Dr. Farmanfarma has contributed to over 20 high-impact publications, focusing on cancer epidemiology, metabolic syndrome, and public health. She is also a co-author of an eBook on the Renin-Angiotensin System and its role in diseases. Her research has earned her awards and recognition both nationally and internationally. 📚🌍🔬

 

Publication profile

Academic Background 🧠

Dr. Khadijeh Kalan Farmanfarma holds a PhD in Epidemiology and an M.Sc. in Health Education and Health Promotion. Her solid academic foundation is supported by multiple recognitions at the doctoral and master’s levels. Her focus on epidemiological research is crucial, particularly during global health challenges like COVID-19.

Research Contributions 📚

Dr. Farmanfarma has an impressive body of work, with more than 25 published research articles across Q1 to Q3 journals. Some highlights include:

COVID-19 Research: Her studies on the impact of COVID-19, especially on domestic violence and illness anxiety, show her commitment to addressing emerging public health issues.

Metabolic Syndrome & Cancer Epidemiology: Dr. Farmanfarma has published meta-analyses on metabolic syndrome and various cancers, which have gained significant attention in high-impact journals like Diabetes & Metabolic Syndrome: Clinical Research & Reviews (IF: 10.0, Q1).

Chronic Diseases & Breast Cancer Prevention: Her focus on chronic diseases and breast cancer prevention demonstrates her dedication to improving population health.

Recognitions 🏆

Dr. Farmanfarma’s accolades include being named the Top National Researcher and Top Researcher at Zahedan University of Medical Sciences multiple times, which speaks to her consistent excellence in research.

Publication Top Notes 

  • 📚 Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies – Cited by: 248 (2018)
  • 📚 Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies – Cited by: 149 (2019)
  • 🧠 Brain cancer in the world: An epidemiological review – Cited by: 79 (2019)
  • 🎗️ Improving Breast Cancer Preventive Behavior among Female Medical Staff: Educational Intervention – Cited by: 59 (2014)
  • 📊 Epidemiologic study of gastric cancer in Iran: A systematic review – Cited by: 51 (2020)
  • 📈 Prevalence of type 2 diabetes in Middle-East: Systematic review & meta-analysis – Cited by: 47 (2020)
  • 🎗️ Effect of education on preventive behaviors of breast cancer in female teachers – Cited by: 35 (2014)
  • 🩺 Study of breast cancer knowledge, attitude, and preventive behaviors in Yazd, Iran – Cited by: 22 (2017)
  • 📊 Prevalence and trend of metabolic syndrome in South-East Iran – Cited by: 21 (2020)
  • 🧬 Testicular cancer in the world: An epidemiological review – Cited by: 20 (2018)

Conclusion 📝

With her extensive research output, recognitions, and focus on significant public health issues, Dr. Khadijeh Kalan Farmanfarma is a strong candidate for the Research for Best Researcher Award. Her diverse and impactful research contributions in epidemiology, particularly in chronic diseases and cancer, reflect a distinguished career deserving of recognition.